financetom
Business
financetom
/
Business
/
Brokerage Charles Schwab's long-time CEO Bettinger to retire
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Brokerage Charles Schwab's long-time CEO Bettinger to retire
Oct 2, 2024 10:10 PM

Oct 1 (Reuters) - Charles Schwab ( SCHW ) said on

Tuesday that President Rick Wurster will succeed long-time CEO

Walt Bettinger as its next chief executive, paving the way for a

change of guard at the brokerage firm after 16 years.

Bettinger, who became CEO in late 2008, will retire from his

role at the end of the year but continue as the executive

co-chair of the board, the company said.

The CEO transition comes at a time when elevated interest

rates have made deposits and debt costly, pressuring the

brokerage firm's earnings in its most recent quarter.

Schwab's shares have fallen nearly 6% this year even amid a

rally in equities.

Under Bettinger, Schwab grew its market capitalization to

$119 billion from $18 billion at the end of 2008. Client assets

also grew more than eight times over the same period.

He oversaw the company's $26-billion acquisition of TD

Ameritrade and eliminated commissions on trading, a move that

helped it win more retail clients.

In an interview with CNBC, Bettinger said he had targeted

2025 as the time to retire.

"We wrapped up the integration of Ameritrade this past

summer. It was really important for me to be here through that

integration and to see it through," Bettinger told CNBC.

Wurster, who will take over on Jan. 1, joined Schwab in

early 2016. Prior to that, he held leadership roles at asset

manager Wellington Management and management consulting firm

McKinsey.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vera Therapeutics Acquires Global Rights to Dual BAFF/APRIL Inhibitor
Vera Therapeutics Acquires Global Rights to Dual BAFF/APRIL Inhibitor
Jan 13, 2025
12:32 PM EST, 01/13/2025 (MT Newswires) -- Vera Therapeutics ( VERA ) said Monday it has secured an exclusive license deal with Stanford University for fusion protein targeting BAFF and APRIL, known as VT-109, with therapeutic potential across the spectrum of B cell mediated diseases. Vera said it will develop and market VT-109 in exchange for undisclosed upfront and milestone...
Italian court to decide soon over Vivendi appeal against TIM's grid sale
Italian court to decide soon over Vivendi appeal against TIM's grid sale
Jan 13, 2025
MILAN (Reuters) - An Italian court is expected to decide this week on a request by Telecom Italia's (TIM) top investor Vivendi to annul the former phone monopoly's decision to sell its landline grid to a consortium led by KKR, a source close to the matter said. Vivendi, which holds 24% of TIM, filed a complaint with a Milan court...
BioMarin Pharmaceutical Sues Ascendis Pharma for Alleged Patent Infringement in Germany
BioMarin Pharmaceutical Sues Ascendis Pharma for Alleged Patent Infringement in Germany
Jan 13, 2025
12:34 PM EST, 01/13/2025 (MT Newswires) -- BioMarin Pharmaceutical ( BMRN ) filed a lawsuit against Ascendis Pharma ( ASND ) in the Unified Patent Court in Munich, claiming infringement of European patent EP 3 175 863 B1. The patent covers long-acting variants of C-Type Natriuretic Peptide, BioMarin said Monday in a statement. Ascendis' TransCon CNP investigational product and its...
European Equities Close Lower in Monday Trading; GSK Agrees to Acquire IDRx
European Equities Close Lower in Monday Trading; GSK Agrees to Acquire IDRx
Jan 13, 2025
12:18 PM EST, 01/13/2025 (MT Newswires) -- The European stock markets closed lower in Monday trading as The Stoxx Europe fell 0.55%, Germany's DAX lost 0.41%, the FTSE in London was down 0.29%, France's CAC declined 0.30%, and the Swiss Market Index dropped 0.76%. The household saving rate in the euro area declined to 15.3% in Q3 of 2024 from...
Copyright 2023-2026 - www.financetom.com All Rights Reserved